Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

The Antidepressant Activity of Matricaria chamomilla and Melissa officinalis Ethanolic Extracts in Non-Reserpinized and Reserpinized Balb/C Mice

Abdolrasoul Namjou 1 , * , Nasser Yazdani 2 , Esmail Abbasi 3 and Mahmoud Rafieian-Kopaei 4
Authors Information
1 Department of Pathology, Faculty of Veterinary Medicine, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
2 Department of Health Sciences, Faculty of Veterinary Public Health, University of Missouri, Columbia, United States
3 Department of Pharmacology, Qazvin University of Medical Sciences, Qazvin, Iran
4 Medical Plants Research Center, Basic Health Sciences Institutes, Shahrekord University of Medical Sciences, Shahrekord, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: November 30, 2018, 13 (4); e65549
  • Published Online: December 2, 2018
  • Article Type: Research Article
  • Received: July 19, 2015
  • Revised: December 25, 2017
  • Accepted: February 24, 2018
  • DOI: 10.5812/jjnpp.65549

To Cite: Namjou A, Yazdani N, Abbasi E, Rafieian-Kopaei M. The Antidepressant Activity of Matricaria chamomilla and Melissa officinalis Ethanolic Extracts in Non-Reserpinized and Reserpinized Balb/C Mice, Jundishapur J Nat Pharm Prod. 2018 ; 13(4):e65549. doi: 10.5812/jjnpp.65549.

Abstract
Copyright © 2018, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Sadeghirad B, Haghdoost AA, Amin-Esmaeili M, Ananloo ES, Ghaeli P, Rahimi-Movaghar A, et al. Epidemiology of major depressive disorder in Iran: A systematic review and meta-analysis. Int J Prev Med. 2010;1(2):81-91. [PubMed: 21566767]. [PubMed Central: PMC3075476].
  • 2. Aktas S, Yesilcicek Calik K. Factors affecting depression during pregnancy and the correlation between social support and pregnancy depression. Iran Red Crescent Med J. 2015;17(9). e16640. doi: 10.5812/ircmj.16640. [PubMed: 26473071]. [PubMed Central: PMC4601205].
  • 3. Petit-Demouliere B, Chenu F, Bourin M. Forced swimming test in mice: A review of antidepressant activity. Psychopharmacology (Berl). 2005;177(3):245-55. doi: 10.1007/s00213-004-2048-7. [PubMed: 15609067].
  • 4. Dhingra D, Chhillar R. Antidepressant-like activity of ellagic acid in unstressed and acute immobilization-induced stressed mice. Pharmacol Rep. 2012;64(4):796-807. [PubMed: 23087132].
  • 5. Gelenberg AJ. The prevalence and impact of depression. J Clin Psychiatry. 2010;71(3). e06. doi: 10.4088/JCP.8001tx17c. [PubMed: 20331925].
  • 6. Cryan JF, Mombereau C. In search of a depressed mouse: Utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry. 2004;9(4):326-57. doi: 10.1038/sj.mp.4001457. [PubMed: 14743184].
  • 7. Santosh P, Venugopl R, Nilakash AS, Kunjbihari S, Mangala L. Antidepressant activity of methanolic extract of Passiflora foetida leaves in mice. Int J Pharm Pharm Sci. 2011;3(1):112-5.
  • 8. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289(23):3135-44. doi: 10.1001/jama.289.23.3135. [PubMed: 12813119].
  • 9. Kawakami N, Takeshima T, Ono Y, Uda H, Hata Y, Nakane Y, et al. Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: Preliminary finding from the World Mental Health Japan Survey 2002-2003. Psychiatry Clin Neurosci. 2005;59(4):441-52. doi: 10.1111/j.1440-1819.2005.01397.x. [PubMed: 16048450].
  • 10. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-105. doi: 10.1001/jama.289.23.3095. [PubMed: 12813115].
  • 11. Bromet EJ, Gluzman SF, Paniotto VI, Webb CP, Tintle NL, Zakhozha V, et al. Epidemiology of psychiatric and alcohol disorders in Ukraine: findings from the Ukraine World Mental Health survey. Soc Psychiatry Psychiatr Epidemiol. 2005;40(9):681-90. doi: 10.1007/s00127-005-0927-9. [PubMed: 16160752].
  • 12. El-Sisi SFI. Evaluation of the antidepressant like effect for some natural supplements against reserpine induced behavioral depression in mice. N Y Sci J. 2011;4(10):93-104.
  • 13. Hosseini Z, Lorigooini Z, Rafieian-Kopaei M, Shirmardi HA, Solati K. A review of botany and pharmacological effect and chemical composition of echinophora species growing in Iran. Pharmacognosy Res. 2017;9(4):305-12. doi: 10.4103/pr.pr_22_17. [PubMed: 29263622]. [PubMed Central: PMC5717781].
  • 14. Yu L, Jiang X, Liao M, Ma R, Yu T. Antidepressant-like effect of tetramethylpyrazine in mice and rats. Neurosci Med. 2011;2(6):142-8. doi: 10.4236/nm.2011.22020.
  • 15. Chenu F, Guiard BP, Bourin M, Gardier AM. Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test. Behav Brain Res. 2006;172(2):256-63. doi: 10.1016/j.bbr.2006.05.011. [PubMed: 16806519].
  • 16. Zimmerman M, Chelminski I, Posternak M. A review of studies of the Hamilton depression rating scale in healthy controls: Implications for the definition of remission in treatment studies of depression. J Nerv Ment Dis. 2004;192(9):595-601. [PubMed: 15348975].
  • 17. Clausius N, Born C, Grunze H. [The relevance of dopamine agonists in the treatment of depression]. Neuropsychiatr. 2009;23(1):15-25. German. [PubMed: 19272288].
  • 18. Can OD, Demir OU, Kiyan HT, Demirci B. Psychopharmacological profile of Chamomile (Matricaria recutita L.) essential oil in mice. Phytomedicine. 2012;19(3-4):306-10. doi: 10.1016/j.phymed.2011.10.001. [PubMed: 22070986].
  • 19. Emamghoreishi M, Talebianpour MS. Antidepressant effect of Melissa officinalis in the forced swimming test. Daru. 2009;17(1):42-7.
  • 20. Namjoo A, MirVakili M, Shirzad H, Faghani M. Biochemical, liver and renal toxicities of Melissa officinals hydroalcoholic extract on balb/C mice. J HerbMed Pharmacol. 2013;2(2):35-40.
  • 21. Chehroudi S, Fatemi MJ, Saberi Isfeedvajani M, Salehi SH, Akbari H, Samimi R. Effects of Melissa officinalis L. on reducing stress, alleviating anxiety disorders, depression, and insomnia, and increasing total antioxidants in burn patients. Trauma Mon. 2016;22(4). e33630. doi: 10.5812/traumamon.33630.
  • 22. Dos Santos-Neto LL, de Vilhena Toledo MA, Medeiros-Souza P, de Souza GA. The use of herbal medicine in Alzheimer's disease-a systematic review. Evid Based Complement Alternat Med. 2006;3(4):441-5. doi: 10.1093/ecam/nel071. [PubMed: 17173107]. [PubMed Central: PMC1697739].
  • 23. OndrejOvič M, Kraic F, BenKOvičOvá H, ŠilHár S. Optimisation of antioxidant extraction from lemon balm (Melissa officinalis). Czech J Food Sci. 2012;30(4):385-93. doi: 10.17221/436/2010-CJFS.
  • 24. Patora J, Klimek B. Flavonoids from lemon balm (Melissa officinalis L., Lamiaceae). Acta Pol Pharm. 2002;59(2):139-43. [PubMed: 12365606].
  • 25. de Carvalho NC, Correa-Angeloni MJ, Leffa DD, Moreira J, Nicolau V, de Aguiar Amaral P, et al. Evaluation of the genotoxic and antigenotoxic potential of Melissa officinalis in mice. Genet Mol Biol. 2011;34(2):290-7. [PubMed: 21734832]. [PubMed Central: PMC3115325].
  • 26. Ibarra A, Feuillere N, Roller M, Lesburgere E, Beracochea D. Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice. Phytomedicine. 2010;17(6):397-403. doi: 10.1016/j.phymed.2010.01.012. [PubMed: 20171069].
  • 27. Kennedy DO, Wightman EL. Herbal extracts and phytochemicals: Plant secondary metabolites and the enhancement of human brain function. Adv Nutr. 2011;2(1):32-50. doi: 10.3945/an.110.000117. [PubMed: 22211188]. [PubMed Central: PMC3042794].
  • 28. Singh O, Khanam Z, Misra N, Srivastava MK. Chamomile (Matricaria chamomilla L.): An overview. Pharmacogn Rev. 2011;5(9):82-95. doi: 10.4103/0973-7847.79103. [PubMed: 22096322]. [PubMed Central: PMC3210003].
  • 29. Avallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P, Baraldi M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochem Pharmacol. 2000;59(11):1387-94. [PubMed: 10751547].
  • 30. Gupta V, Mittal P, Bansal P, Khokra SL, Kaushik D. Pharmacological potential of Matricaria recutita-A review. Int J Pharm Sci Drug Res. 2010;2(1):12-6.
  • 31. Gong J, Huang J, Ge Q, Chen F, Zhang Y. Advanced research on the antidepressant effect of flavonoids. Curr Opin Complement Altern Med. 2014;1(2). e00011. doi: 10.7178/cocam.00011.
  • 32. Areias FM, Rego AC, Oliveira CR, Seabra RM. Antioxidant effect of flavonoids after ascorbate/Fe(2+)-induced oxidative stress in cultured retinal cells. Biochem Pharmacol. 2001;62(1):111-8. [PubMed: 11377402].
  • 33. Selvi PT, Kumar MS, Rajesh R, Kathiravan T. Antidepressant activity of ethanolic extract of leaves of Centella asiatica. Linn by In vivo methods. Asian J Res Pharm Sci. 2012;2(2):76-9.
  • 34. Abdel-Majeed S, Mohammad A, Shaima AB, Mohammad R, Mousa SA. Inhibition property of green tea extract in relation to reserpine-induced ribosomal strips of rough endoplasmic reticulum (rER) of the rat kidney proximal tubule cells. J Toxicol Sci. 2009;34(6):637-45. [PubMed: 19952499].
  • 35. Ottani A, Ferrari F, Giuliani D. Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(1):91-6. [PubMed: 11853125].
  • 36. Costa AP, Vieira C, Bohner LO, Silva CF, Santos EC, De Lima TC, et al. A proposal for refining the forced swim test in Swiss mice. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:150-5. doi: 10.1016/j.pnpbp.2013.05.002. [PubMed: 23665107].
  • 37. Abelaira HM, Reus GZ, Quevedo J. Animal models as tools to study the pathophysiology of depression. Braz J Psychiatr. 2013;35 Suppl 2:S112-20. doi: 10.1590/1516-4446-2013-1098. [PubMed: 24271223].
  • 38. Delgado PL. Depression: the case for a monoamine deficiency. J Clin Psychiatry. 2000;61 Suppl 6:7-11. [PubMed: 10775018].
  • 39. Elhwuegi AS. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(3):435-51. doi: 10.1016/j.pnpbp.2003.11.018. [PubMed: 15093950].
  • 40. Moallem SA, Hosseinzadeh H, Ghoncheh F. Evaluation of antidepressant effects of aerial parts of Echium vulgare on mice. Iran J Basic Med Sci. 2007;10(3):189-96. doi: 10.22038/IJBMS.2007.5294.
  • 41. Zhen L, Zhu J, Zhao X, Huang W, An Y, Li S, et al. The antidepressant-like effect of fisetin involves the serotonergic and noradrenergic system. Behav Brain Res. 2012;228(2):359-66. doi: 10.1016/j.bbr.2011.12.017. [PubMed: 22197297].
  • 42. Bandaruk Y, Mukai R, Kawamura T, Nemoto H, Terao J. Evaluation of the inhibitory effects of quercetin-related flavonoids and tea catechins on the monoamine oxidase-A reaction in mouse brain mitochondria. J Agric Food Chem. 2012;60(41):10270-7. doi: 10.1021/jf303055b. [PubMed: 23009399].
  • 43. Jager AK, Saaby L. Flavonoids and the CNS. Molecules. 2011;16(2):1471-85. doi: 10.3390/molecules16021471. [PubMed: 21311414].
  • 44. Yi LT, Li CF, Zhan X, Cui CC, Xiao F, Zhou LP, et al. Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(7):1223-8. doi: 10.1016/j.pnpbp.2010.06.024. [PubMed: 20603175].
  • 45. Esposito E. Serotonin-dopamine interaction as a focus of novel antidepressant drugs. Curr Drug Targets. 2006;7(2):177-85. [PubMed: 16475959].
  • 46. Patil R, Dhawale K, Gound H, Gadakh R. Protective effect of leaves of murraya koenigii on reserpine-induced orofacial dyskinesia. Iran J Pharm Res. 2012;11(2):635-41. [PubMed: 24250488]. [PubMed Central: PMC3832166].
  • 47. Lopez V, Martin S, Gomez-Serranillos MP, Carretero ME, Jager AK, Calvo MI. Neuroprotective and neurological properties of Melissa officinalis. Neurochem Res. 2009;34(11):1955-61. doi: 10.1007/s11064-009-9981-0. [PubMed: 19760174].
  • 48. Celada P, Puig M, Amargos-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci. 2004;29(4):252-65. [PubMed: 15309042]. [PubMed Central: PMC446220].
  • 49. Reus GZ, Stringari RB, de Souza B, Petronilho F, Dal-Pizzol F, Hallak JE, et al. Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxid Med Cell Longev. 2010;3(5):325-31. [PubMed: 21150338]. [PubMed Central: PMC3154037].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments